P
Paul McMaster
Researcher at Queen Elizabeth Hospital Birmingham
Publications - 140
Citations - 6369
Paul McMaster is an academic researcher from Queen Elizabeth Hospital Birmingham. The author has contributed to research in topics: Liver transplantation & Transplantation. The author has an hindex of 44, co-authored 140 publications receiving 6246 citations. Previous affiliations of Paul McMaster include University of Birmingham & Children's of Alabama.
Papers
More filters
Journal ArticleDOI
Evolution of liver transplantation in Europe: Report of the European liver transplant registry
René Adam,Paul McMaster,John O'Grady,Denis Castaing,Jürgen Klempnauer,Neville V. Jamieson,Peter Neuhaus,Jan Lerut,Mauro Salizzoni,Stephen Pollard,Ferdinand Mühlbacher,Xavier Rogiers,Juan Carlos Garcia Valdecasas,Joaquín Berenguer,Daniel Jaeck,Enrique Moreno González +15 more
TL;DR: One of the most important findings in the evolution of LT is the considerable improvement of results along time with, for the mean time, a one‐year survival of 83%, all indications confounded.
Journal ArticleDOI
Lamivudine prophylaxis against reinfection in liver transplantation for hepatitis B cirrhosis
Leonie Grellier,David Mutimer,M. M. Ahmed,Dave Brown,Andrew K. Burroughs,Keith Rolles,Paul McMaster,P Beranek,F Kennedy,H Kibbler,Penny McPhillips,Elwyn Elias,Geoff Dusheiko +12 more
TL;DR: Lamivudine treatment may prove useful in preventing recurrence of hepatitis B after liver transplantation and the effect on survival of patients after transplantation remains to be assessed.
Journal ArticleDOI
Normalised intrinsic mortality risk in liver transplantation: European Liver Transplant Registry study.
R. Adam,Valérie Cailliez,Pietro Majno,Vincent Karam,Paul McMaster,Roy Y. Calne,John O'Grady,Rudolf Pichlmayr,Peter Neuhaus,Jean-Bernard Otte,Krister Hoeckerstedt,Henri Bismuth +11 more
TL;DR: The normalised intrinsic mortality risk can be combined with the relative risk ratios of known risk factors to better estimate the mortality risk of a given procedure in a given patient.
Journal ArticleDOI
Neurological complications following liver transplantation
David H. Adams,Bridget Gunson,L. Honigsberger,John A. C. Buckels,S. Ponsford,A.P. Boon,A. C. Williams,Elwyn Elias,Paul McMaster +8 more
TL;DR: In some patients the evidence implicating cyclosporin in the development of fits is strong, and in others factors such as electrolyte disturbances, steroid treatment for graft rejection, and cerebral infarction may have contributed to theDevelopment of the fits.
Journal ArticleDOI
Transplantation for primary biliary cirrhosis: Retrospective analysis of 400 patients in a single center
TL;DR: PBC remains a good indication for liver transplantation, with excellent survival rates, although the age at transplantation increased although patients tended to be grafted earlier and survival rates have increased although there is a reduction in the survival benefit.